annual EBITDA:
$23.07M+$99.43M(+130.21%)Summary
- As of today (August 22, 2025), EXAS annual EBITDA is $23.07 million, with the most recent change of +$99.43 million (+130.21%) on December 31, 2024.
- During the last 3 years, EXAS annual EBITDA has risen by +$546.11 million (+104.41%).
- EXAS annual EBITDA is now at all-time high.
Performance
EXAS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$58.05M+$102.03M(+231.97%)Summary
- As of today (August 22, 2025), EXAS quarterly EBITDA is $58.05 million, with the most recent change of +$102.03 million (+231.97%) on June 30, 2025.
- Over the past year, EXAS quarterly EBITDA has increased by +$26.95 million (+86.68%).
- EXAS quarterly EBITDA is now at all-time high.
Performance
EXAS quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$51.09M+$26.95M(+111.66%)Summary
- As of today (August 22, 2025), EXAS TTM EBITDA is $51.09 million, with the most recent change of +$26.95 million (+111.66%) on June 30, 2025.
- Over the past year, EXAS TTM EBITDA has increased by +$111.67 million (+184.34%).
- EXAS TTM EBITDA is now at all-time high.
Performance
EXAS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EXAS EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +130.2% | +86.7% | +184.3% |
3 y3 years | +104.4% | +187.8% | +110.8% |
5 y5 years | +120.0% | +225.9% | +140.8% |
EXAS EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +104.4% | at high | +184.1% | at high | +110.8% |
5 y | 5-year | at high | +104.4% | at high | +124.1% | at high | +109.0% |
alltime | all time | at high | +104.4% | at high | +124.1% | at high | +109.0% |
EXAS EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $58.05M(-232.0%) | $51.09M(+111.7%) |
Mar 2025 | - | -$43.98M(-486.7%) | $24.14M(+66.6%) |
Dec 2024 | $23.07M(-130.2%) | $11.37M(-55.7%) | $14.48M(-166.0%) |
Sep 2024 | - | $25.66M(-17.5%) | -$21.95M(-63.8%) |
Jun 2024 | - | $31.09M(-158.0%) | -$60.58M(-45.2%) |
Mar 2024 | - | -$53.64M(+114.0%) | -$110.64M(+42.8%) |
Dec 2023 | -$76.36M(-80.7%) | -$25.06M(+93.2%) | -$77.47M(-31.6%) |
Sep 2023 | - | -$12.97M(-31.6%) | -$113.19M(-33.1%) |
Jun 2023 | - | -$18.97M(-7.4%) | -$169.25M(-21.8%) |
Mar 2023 | - | -$20.47M(-66.3%) | -$216.40M(-37.2%) |
Dec 2022 | -$394.72M(-24.5%) | -$60.78M(-11.9%) | -$344.58M(-24.2%) |
Sep 2022 | - | -$69.03M(+4.4%) | -$454.58M(-3.9%) |
Jun 2022 | - | -$66.12M(-55.5%) | -$472.83M(-1.0%) |
Mar 2022 | - | -$148.66M(-13.0%) | -$477.45M(-16.2%) |
Dec 2021 | -$523.04M(-2511.8%) | -$170.77M(+95.7%) | -$569.60M(+59.7%) |
Sep 2021 | - | -$87.28M(+23.4%) | -$356.74M(+65.3%) |
Jun 2021 | - | -$70.74M(-70.6%) | -$215.82M(+12.9%) |
Mar 2021 | - | -$240.80M(-672.2%) | -$191.19M(-2023.2%) |
Dec 2020 | $21.69M(-118.8%) | $42.09M(-21.5%) | $9.94M(-121.7%) |
Sep 2020 | - | $53.64M(-216.3%) | -$45.77M(-63.4%) |
Jun 2020 | - | -$46.11M(+16.2%) | -$125.06M(+20.2%) |
Mar 2020 | - | -$39.67M(+191.1%) | -$104.08M(-16.4%) |
Dec 2019 | -$115.31M(-15.5%) | -$13.63M(-46.9%) | -$124.47M(-18.8%) |
Sep 2019 | - | -$25.65M(+2.0%) | -$153.27M(-5.6%) |
Jun 2019 | - | -$25.14M(-58.1%) | -$162.39M(-1.5%) |
Mar 2019 | - | -$60.06M(+41.6%) | -$164.81M(+20.8%) |
Dec 2018 | -$136.39M(+32.7%) | -$42.43M(+22.0%) | -$136.39M(+21.1%) |
Sep 2018 | - | -$34.77M(+26.1%) | -$112.64M(+10.2%) |
Jun 2018 | - | -$27.56M(-12.9%) | -$102.22M(-0.1%) |
Mar 2018 | - | -$31.64M(+69.3%) | -$102.33M(-0.5%) |
Dec 2017 | -$102.75M(-34.8%) | -$18.68M(-23.2%) | -$102.89M(-13.4%) |
Sep 2017 | - | -$24.34M(-12.0%) | -$118.84M(-8.4%) |
Jun 2017 | - | -$27.67M(-14.1%) | -$129.74M(-10.1%) |
Mar 2017 | - | -$32.19M(-7.1%) | -$144.34M(-8.4%) |
Dec 2016 | -$157.51M(+4.1%) | -$34.64M(-1.7%) | -$157.51M(-2.2%) |
Sep 2016 | - | -$35.24M(-16.6%) | -$161.10M(-3.6%) |
Jun 2016 | - | -$42.27M(-6.8%) | -$167.20M(+2.9%) |
Mar 2016 | - | -$45.36M(+18.6%) | -$162.50M(+7.2%) |
Dec 2015 | -$151.32M(+56.3%) | -$38.23M(-7.5%) | -$151.57M(+4.9%) |
Sep 2015 | - | -$41.34M(+10.0%) | -$144.47M(+7.5%) |
Jun 2015 | - | -$37.58M(+9.2%) | -$134.43M(+16.2%) |
Mar 2015 | - | -$34.42M(+10.6%) | -$115.73M(+19.5%) |
Dec 2014 | -$96.83M(+113.5%) | -$31.14M(-0.5%) | -$96.83M(+24.9%) |
Sep 2014 | - | -$31.29M(+65.7%) | -$77.52M(+35.6%) |
Jun 2014 | - | -$18.88M(+21.6%) | -$57.15M(+13.6%) |
Mar 2014 | - | -$15.52M(+31.3%) | -$50.28M(+10.9%) |
Dec 2013 | -$45.34M(-12.2%) | -$11.82M(+8.3%) | -$45.34M(-4.0%) |
Sep 2013 | - | -$10.92M(-9.2%) | -$47.24M(-3.8%) |
Jun 2013 | - | -$12.02M(+13.6%) | -$49.08M(-5.1%) |
Mar 2013 | - | -$10.58M(-22.9%) | -$51.74M(+0.2%) |
Dec 2012 | -$51.66M | -$13.72M(+7.6%) | -$51.66M(+22.4%) |
Sep 2012 | - | -$12.76M(-13.1%) | -$42.20M(+13.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | -$14.68M(+39.8%) | -$37.16M(+27.9%) |
Mar 2012 | - | -$10.50M(+146.2%) | -$29.05M(+26.9%) |
Dec 2011 | -$28.42M(+145.1%) | -$4.26M(-44.8%) | -$22.89M(+2.3%) |
Sep 2011 | - | -$7.73M(+17.7%) | -$22.39M(+24.4%) |
Jun 2011 | - | -$6.56M(+51.4%) | -$17.99M(+29.9%) |
Mar 2011 | - | -$4.33M(+15.3%) | -$13.86M(+19.5%) |
Dec 2010 | -$11.60M(+40.1%) | -$3.76M(+12.8%) | -$11.60M(+20.6%) |
Sep 2010 | - | -$3.33M(+37.4%) | -$9.62M(+31.0%) |
Jun 2010 | - | -$2.43M(+17.0%) | -$7.34M(-0.0%) |
Mar 2010 | - | -$2.08M(+16.6%) | -$7.34M(-18.7%) |
Dec 2009 | -$8.28M(-5.4%) | -$1.78M(+68.2%) | -$9.04M(-1.5%) |
Sep 2009 | - | -$1.06M(-56.4%) | -$9.17M(-13.2%) |
Jun 2009 | - | -$2.43M(-35.6%) | -$10.56M(+6.0%) |
Mar 2009 | - | -$3.77M(+96.8%) | -$9.96M(+13.9%) |
Dec 2008 | -$8.74M(-20.9%) | -$1.92M(-21.8%) | -$8.74M(-17.4%) |
Sep 2008 | - | -$2.45M(+33.7%) | -$10.58M(-8.6%) |
Jun 2008 | - | -$1.83M(-28.2%) | -$11.58M(-1.0%) |
Mar 2008 | - | -$2.55M(-32.0%) | -$11.69M(+5.7%) |
Dec 2007 | -$11.06M(-11.2%) | -$3.75M(+9.1%) | -$11.06M(+21.0%) |
Sep 2007 | - | -$3.44M(+77.1%) | -$9.14M(+5.2%) |
Jun 2007 | - | -$1.94M(+1.3%) | -$8.69M(-12.3%) |
Mar 2007 | - | -$1.92M(+4.5%) | -$9.90M(-18.3%) |
Dec 2006 | -$12.45M(-9.1%) | -$1.84M(-38.5%) | -$12.13M(-6.1%) |
Sep 2006 | - | -$2.99M(-5.5%) | -$12.91M(-1.2%) |
Jun 2006 | - | -$3.16M(-23.7%) | -$13.06M(-5.1%) |
Mar 2006 | - | -$4.14M(+58.1%) | -$13.76M(+2.1%) |
Dec 2005 | -$13.70M(-21.6%) | -$2.62M(-16.6%) | -$13.48M(-11.3%) |
Sep 2005 | - | -$3.14M(-18.6%) | -$15.19M(-6.3%) |
Jun 2005 | - | -$3.86M(+0.0%) | -$16.20M(-1.1%) |
Mar 2005 | - | -$3.86M(-10.9%) | -$16.38M(-6.2%) |
Dec 2004 | -$17.47M(-32.9%) | -$4.33M(+4.0%) | -$17.47M(-4.8%) |
Sep 2004 | - | -$4.16M(+3.0%) | -$18.34M(-9.6%) |
Jun 2004 | - | -$4.04M(-18.3%) | -$20.29M(-13.7%) |
Mar 2004 | - | -$4.94M(-5.0%) | -$23.50M(-9.7%) |
Dec 2003 | -$26.03M(-9.3%) | -$5.20M(-14.9%) | -$26.03M(-4.9%) |
Sep 2003 | - | -$6.11M(-15.7%) | -$27.38M(-3.4%) |
Jun 2003 | - | -$7.25M(-2.9%) | -$28.34M(-1.4%) |
Mar 2003 | - | -$7.46M(+13.9%) | -$28.74M(+0.2%) |
Dec 2002 | -$28.69M(+14.4%) | -$6.55M(-7.4%) | -$28.69M(+0.9%) |
Sep 2002 | - | -$7.07M(-7.5%) | -$28.44M(+3.8%) |
Jun 2002 | - | -$7.65M(+3.2%) | -$27.39M(+5.2%) |
Mar 2002 | - | -$7.41M(+17.6%) | -$26.04M(+5.8%) |
Dec 2001 | -$25.08M(+94.0%) | -$6.30M(+4.5%) | -$24.62M(+3.6%) |
Sep 2001 | - | -$6.03M(-4.3%) | -$23.76M(+34.0%) |
Jun 2001 | - | -$6.30M(+5.2%) | -$17.73M(+55.1%) |
Mar 2001 | - | -$5.99M(+10.0%) | -$11.43M(+114.0%) |
Dec 2000 | -$12.93M(+167.1%) | - | - |
Dec 2000 | - | -$5.44M(-5506.0%) | -$5.34M(-5406.0%) |
Mar 2000 | - | $100.70K | $100.70K |
Dec 1999 | -$4.84M(+28.1%) | - | - |
Dec 1998 | -$3.78M(+96.5%) | - | - |
Dec 1997 | -$1.92M | - | - |
FAQ
- What is Exact Sciences Corporation annual EBITDA?
- What is the all time high annual EBITDA for Exact Sciences Corporation?
- What is Exact Sciences Corporation annual EBITDA year-on-year change?
- What is Exact Sciences Corporation quarterly EBITDA?
- What is the all time high quarterly EBITDA for Exact Sciences Corporation?
- What is Exact Sciences Corporation quarterly EBITDA year-on-year change?
- What is Exact Sciences Corporation TTM EBITDA?
- What is the all time high TTM EBITDA for Exact Sciences Corporation?
- What is Exact Sciences Corporation TTM EBITDA year-on-year change?
What is Exact Sciences Corporation annual EBITDA?
The current annual EBITDA of EXAS is $23.07M
What is the all time high annual EBITDA for Exact Sciences Corporation?
Exact Sciences Corporation all-time high annual EBITDA is $23.07M
What is Exact Sciences Corporation annual EBITDA year-on-year change?
Over the past year, EXAS annual EBITDA has changed by +$99.43M (+130.21%)
What is Exact Sciences Corporation quarterly EBITDA?
The current quarterly EBITDA of EXAS is $58.05M
What is the all time high quarterly EBITDA for Exact Sciences Corporation?
Exact Sciences Corporation all-time high quarterly EBITDA is $58.05M
What is Exact Sciences Corporation quarterly EBITDA year-on-year change?
Over the past year, EXAS quarterly EBITDA has changed by +$26.95M (+86.68%)
What is Exact Sciences Corporation TTM EBITDA?
The current TTM EBITDA of EXAS is $51.09M
What is the all time high TTM EBITDA for Exact Sciences Corporation?
Exact Sciences Corporation all-time high TTM EBITDA is $51.09M
What is Exact Sciences Corporation TTM EBITDA year-on-year change?
Over the past year, EXAS TTM EBITDA has changed by +$111.67M (+184.34%)